Abstract

Introduction. Tropolone alkaloid – colchicine, there is very interesting object for synthesis of its derivatives, with such properties as, alkylation, a low toxicity, high antineoplastic activity and especially overcoming of multidrug resistance (MDR). We had been developed the antineoplastic preparation К-26 derivative of colchicine. К-26 has shown high cytotoxic activity on 60 lines of tumoral cells of the human in vitro, at National Institute of the Cancer of the USA (NCI). Further on the basis of К-26 its water-soluble form named term К-26w has been received. The work purpose. Studying of the mechanism of action of preparations К-26 and К-26w on: alkylating ability, mitotic activity, topoisomerase II, MDR2, р53 and colony-forming cells spleen (CFCs). Materials and methods. All researches have been carrying out by a standard technique. Studying mitotic activity of preparations was carrying out on duodenum and tumor СаРа after preparation influence. On models of a tumor of the Sarcoma 180 action of preparations has been investigated: the alkylating - on synthesis DNA/RNA, nucleosoma DNA degradation, activity topoisomerase II; on an expression MDR2 and р53 genes. Studying CFCs carry out by a standard technique on outbred mice. Results. К-26, К-26w and etoposide inhibited in cells of the Sarcoma 180: synthesis DNA/RNA on 84/65%, 95/85% and 55/35%, accordingly, in relation to the control; activity topoisomerase II on 80%, 90% and 60% accordingly. By method RT-PCR it is shown, К-26, К-26w and etoposide: inhibited an expression of MDR2 gene on 83%, 91% and 62%; increase expression р53 gene to 74%, 88% and 55%, accordingly, under the relation of the control of referential gene GARDH (100%). High ability К-26 and К-26w in an induction apoptosis tumoral cells and CFCs to 12 units is shown. Conclusion. Revealed ability К-26 and К-26w to suppress synthesis DNA/RNA activity topoisomerases, to stimulate р53, and also to suppress an expression of a multidrug resistance MDR2 gene, it explains their high antineoplastic activity which is connected with mitotic activity leading to cell fission synchronization, and radiosensitization activity. Special interest represents found at К-26w and К-26 suppression MDR2 as they are aimed for treatment of such resistant tumor as a kidney cancer. Stimulation CFCs which provides formation of haemopoetic and immune cells can protect an organism from their intensive cytotoxic action.

Highlights

  • Tropolone alkaloid – colchicine, there is very interesting object for synthesis of its derivatives, with such properties as, alkylation, a low toxicity, high antineoplastic activity and especially overcoming of multidrug resistance (MDR)

  • Activity of Preparations К-26 and K-26w this property is necessary for its derivative as potential antineoplastic preparations

  • Mitotic index (MI) epithelial crypt on bowels [7], in various terms after introduction К-26 in comparison with initial colchicine it is shown, that the maximum delay mitotic divisions observed at introduction colchicine (35.73±0.26%) after 6 hours, and for К-26 MI were more low- about 23%, in comparison with the control on 19% above

Read more

Summary

Introduction

By us ability of these substances to strengthen irradiation action on intact mice with entered К-26 and К26w to an irradiation in a dose 1/3 from LD16, is shown, that has caused the big destruction of animals, than in the control, and value FCD (the factor changing doses) equal 0.65-0.7 has been found [5, 6] It causes them radiosensitization action, thereupon we suppose to study new antineoplastic preparations К-26 and К-26w on animals with tumors as a radio sensitizer with antineoplastic action for parenteral (К26w) and external application (К-26). Purpose of the present research was studying mitotic and alkylating activity, influence on topoisomerase II, on drug resistance and р53, and on CFCs of new preparations

Tumoral Strains
Antitumor Drugs
Animals
Mitotic Activity
Alkylating Action
Rt-pcr
Results and Discussion
The Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call